PlainRecalls
FDA Drug Moderate Class II Terminated

DORAMA-NEO (naphazoline hydrochloride) Eye wash, packaged in 0.5 FL OZ (15mL) bottles, Manufactured by SATO Pharmaceuticals CO., LTD. 1-5-27 Motoakasaka Minato-Ku Tokyo, Japan, NDC 49873-020-01

Reported: May 31, 2017 Initiated: February 16, 2017 #D-0856-2017

Product Description

DORAMA-NEO (naphazoline hydrochloride) Eye wash, packaged in 0.5 FL OZ (15mL) bottles, Manufactured by SATO Pharmaceuticals CO., LTD. 1-5-27 Motoakasaka Minato-Ku Tokyo, Japan, NDC 49873-020-01

Reason for Recall

Lack of Assurance of Sterility: Firm failed to establish an adequate system for monitoring environmental conditions in aseptic processing areas.

Details

Recalling Firm
Sato Pharmaceutical Inc.
Units Affected
14,325 bottles
Distribution
US: Hawaii, Guam, Saipan, SPI
Location
Torrance, CA

Frequently Asked Questions

What product was recalled?
DORAMA-NEO (naphazoline hydrochloride) Eye wash, packaged in 0.5 FL OZ (15mL) bottles, Manufactured by SATO Pharmaceuticals CO., LTD. 1-5-27 Motoakasaka Minato-Ku Tokyo, Japan, NDC 49873-020-01. Recalled by Sato Pharmaceutical Inc.. Units affected: 14,325 bottles.
Why was this product recalled?
Lack of Assurance of Sterility: Firm failed to establish an adequate system for monitoring environmental conditions in aseptic processing areas.
Which agency issued this recall?
This recall was issued by the FDA Drug on May 31, 2017. Severity: Moderate. Recall number: D-0856-2017.